Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Insite Vision Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Robert Mayo who wrote (593)	12/25/1997 2:55:00 PM
From: David Bogdanoff	Read Replies (2) \| Respond to of 1060

RM; Timing, as they say, is everything. Take a look at another MM pick: Core Therapeutics. It is now near an all time high after years of basically dead money. Unfortunately, MM's timing on this one was naive in the extreme and he called for selling above 9 a few months ago, only to see it progress steadily to its current price above 20 and holding despite the biotech slide. Similarly, ICOS has done very well recently. Another small pharmaceutical is North American Vaccine which is above water for me and apparently not far away from profitability. Dead money is beat by the money market, but not by a bear market. :) Merry Christmas, David